Document Detail


Thrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction?
MedLine Citation:
PMID:  9385334     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The best technique for reestablishing blood flow after myocardial infarction has been the subject of heated debate for more than a decade. An the answer is still elusive. Which option is the safest? Which salvages the most heart tissue? Dr Faxon explains the pros and cons of both thrombolysis and angioplasty and discusses the "90 rule," which helps determine the optimal reperfusion strategy for each individual patient.
Authors:
D P Faxon
Related Documents :
1829574 - Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial i...
6578454 - Coronary care at hutt hospital 1980-1981.
11676944 - Comparison of primary coronary angioplasty versus thrombolysis in patients with st-segm...
19105114 - Mechanical embolectomy in acute ischaemic stroke--report of the first two cases.
23008134 - Ecg and echocardiographic findings in 10-15-year-old elite athletes.
15127984 - Common scenarios to clarify the interpretation of cardiac markers.
Publication Detail:
Type:  Comparative Study; Journal Article; Review    
Journal Detail:
Title:  Postgraduate medicine     Volume:  102     ISSN:  0032-5481     ISO Abbreviation:  Postgrad Med     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1997-12-18     Completed Date:  1997-12-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401147     Medline TA:  Postgrad Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  97-8, 103-4, 107-8 passim     Citation Subset:  AIM; IM    
Affiliation:
University of Southern California School of Medicine 90033, USA. dfaxon@hsc.usc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Clinical Trials as Topic
Fibrinolytic Agents / therapeutic use
Humans
Myocardial Infarction / drug therapy*,  mortality,  therapy*
Thrombolytic Therapy* / adverse effects,  contraindications
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of acute myocardial infarction. Synopsis of ACC and AHA practice guidelines. American Col...
Next Document:  Role of cardiac markers in evaluation of suspected myocardial infarction. Selecting the most clinica...